Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival: a large cohort study of the German network for systemic sclerosis

Background: Pulmonary involvement is the leading cause of death in systemic sclerosis (SSc) and may manifest as interstitial lung disease (ILD), pulmonary arterial hypertension (PAH), or in combination of both (ILD with pulmonary hypertension [ILD-PH]). The aim of this analysis was to determine prev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Moinzadeh, Pia (VerfasserIn) , Bonella, Francesco (VerfasserIn) , Oberste-Frielinghaus, Max (VerfasserIn) , Weliwitage, Jithmi (VerfasserIn) , Blank, Norbert (VerfasserIn) , Riemekasten, Gabriela (VerfasserIn) , Müller-Ladner, Ulf (VerfasserIn) , Henes, Jörg Christoph (VerfasserIn) , Siegert, Elise (VerfasserIn) , Günther, Claudia (VerfasserIn) , Kötter, Ina (VerfasserIn) , Pfeiffer, Christiane (VerfasserIn) , Schmalzing, Marc (VerfasserIn) , Zeidler, Gabriele (VerfasserIn) , Korsten, Peter (VerfasserIn) , Susok, Laura (VerfasserIn) , Juche, Aaron (VerfasserIn) , Worm, Margitta (VerfasserIn) , Jandová, Ilona (VerfasserIn) , Ehrchen, Jan (VerfasserIn) , Sunderkötter, Cord (VerfasserIn) , Keyßer, Gernot (VerfasserIn) , Ramming, Andreas (VerfasserIn) , Schmeiser, Tim (VerfasserIn) , Kreuter, Alexander (VerfasserIn) , Lorenz, Hanns-Martin (VerfasserIn) , Hunzelmann, Nicolas (VerfasserIn) , Kreuter, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: January 2024
In: Chest
Year: 2024, Jahrgang: 165, Heft: 1, Pages: 132-145
ISSN:1931-3543
DOI:10.1016/j.chest.2023.08.013
Online-Zugang:Resolving-System, kostenfrei: https://doi.org/10.1016/j.chest.2023.08.013
Volltext
Verfasserangaben:Pia Moinzadeh, MD, Francesco Bonella, MD, Max Oberste, BScPsych, Jithmi Weliwitage, MSc, Nobert Blank, MD, Gabriela Riemekasten, MD, Ulf Müller-Ladner, MD, Jörg Henes, MD, Elise Siegert, MD, Claudia Günther, MD, Ina Kötter, MD, Christiane Pfeiffer, MD, Marc Schmalzing, MD, Gabriele Zeidler, MD, Peter Korsten, MD, Laura Susok, MD, Aaron Juche, MD, Margitta Worm, MD, Ilona Jandova, MD, Jan Ehrchen, MD, Cord Sunderkötter, MD, Gernot Keyßer, MD, Andreas Ramming, MD, Tim Schmeiser, MD, Alexander Kreuter, MD, Hanns-Martin Lorenz, MD, Nicolas Hunzelmann, MD, and Michael Kreuter, MD

MARC

LEADER 00000caa a2200000 c 4500
001 1885170521
003 DE-627
005 20250116220321.0
007 cr uuu---uuuuu
008 240405s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.chest.2023.08.013  |2 doi 
035 |a (DE-627)1885170521 
035 |a (DE-599)KXP1885170521 
035 |a (OCoLC)1475287420 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Moinzadeh, Pia  |d 1980-  |e VerfasserIn  |0 (DE-588)132371715  |0 (DE-627)521912776  |0 (DE-576)299104249  |4 aut 
245 1 0 |a Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival  |b a large cohort study of the German network for systemic sclerosis  |c Pia Moinzadeh, MD, Francesco Bonella, MD, Max Oberste, BScPsych, Jithmi Weliwitage, MSc, Nobert Blank, MD, Gabriela Riemekasten, MD, Ulf Müller-Ladner, MD, Jörg Henes, MD, Elise Siegert, MD, Claudia Günther, MD, Ina Kötter, MD, Christiane Pfeiffer, MD, Marc Schmalzing, MD, Gabriele Zeidler, MD, Peter Korsten, MD, Laura Susok, MD, Aaron Juche, MD, Margitta Worm, MD, Ilona Jandova, MD, Jan Ehrchen, MD, Cord Sunderkötter, MD, Gernot Keyßer, MD, Andreas Ramming, MD, Tim Schmeiser, MD, Alexander Kreuter, MD, Hanns-Martin Lorenz, MD, Nicolas Hunzelmann, MD, and Michael Kreuter, MD 
264 1 |c January 2024 
300 |b Diagramme 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 13. August 2023, Artikelversion: 8. Januar 2024 
520 |a Background: Pulmonary involvement is the leading cause of death in systemic sclerosis (SSc) and may manifest as interstitial lung disease (ILD), pulmonary arterial hypertension (PAH), or in combination of both (ILD with pulmonary hypertension [ILD-PH]). The aim of this analysis was to determine prevalence, clinical characteristics, and survival of these different forms within the registry of the German Network for Systemic Sclerosis. Research Question: Does SSc-associated ILD-PH or ILD without PH affect survival differently, and are there any risk factors that have an additional impact? Study Design and Methods: Clinical data of 5,831 patients with SSc were collected in the German Network for Systemic Sclerosis registry. Kaplan-Meier estimates were used to compare overall survival in patients with SSc-associated ILD-PH and ILD without PH with patients without pulmonary involvement and those with PAH. The Cox proportional hazard model was used to analyze the influence of pulmonary involvement and other potential predictors on patient survival. Results: Clinical data of 3,257 patients with a mean follow-up time of 3.45 ± 1.63 years have been included in our analysis. At baseline, ILD was present in 34.5%, whereas PH without ILD had a lower prevalence with 4.5%. At the end of follow-up, 47.6% of patients with SSc had ILD, 15.2% had ILD-PH, and 6.5% had PAH. ILD was more frequent in the diffuse cutaneous form (57.3%), whereas PAH did not differ significantly between SSc subtypes. Significant differences in baseline characteristics between PAH vs ILD-PH vs ILD without PH were found for age at diagnosis, sex, SSc subsets, antibody status, FVC, diffusing capacity of the lung for carbon monoxide, and therapy. Overall survival at 5 years was 96.4% for patients without pulmonary involvement and differed significantly between patients with ILD without PH, PAH, and being worst in patients with ILD-PH. Female sex (hazard ratio [HR], 0.3), higher BMI (HR, 0.9), and higher diffusing capacity of the lung for carbon monoxide values (HR, 0.98) were associated with a lower mortality risk. Interpretation: ILD is the most prevalent pulmonary involvement in SSc, whereas the combination of ILD and PH is associated with the most detrimental survival. 
540 |q DE-3  |a Namensnennung - Nicht kommerziell - Keine Bearbeitungen 4.0 International  |f CC BY-NC-ND 4.0  |2 cc  |u https://creativecommons.org/licenses/by-nc-nd/4.0/ 
700 1 |a Bonella, Francesco  |e VerfasserIn  |0 (DE-588)1188737015  |0 (DE-627)166764534X  |4 aut 
700 1 |a Oberste-Frielinghaus, Max  |e VerfasserIn  |0 (DE-588)140230556  |0 (DE-627)703607553  |0 (DE-576)315392762  |4 aut 
700 1 |a Weliwitage, Jithmi  |e VerfasserIn  |4 aut 
700 1 |a Blank, Norbert  |d 1964-  |e VerfasserIn  |0 (DE-588)115586032  |0 (DE-627)691431507  |0 (DE-576)289963508  |4 aut 
700 1 |a Riemekasten, Gabriela  |d 1965-  |e VerfasserIn  |0 (DE-588)125842406  |0 (DE-627)370708245  |0 (DE-576)295325119  |4 aut 
700 1 |a Müller-Ladner, Ulf  |d 1964-  |e VerfasserIn  |0 (DE-588)13143926X  |0 (DE-627)521406617  |0 (DE-576)298478803  |4 aut 
700 1 |a Henes, Jörg Christoph  |d 1976-  |e VerfasserIn  |0 (DE-588)130088242  |0 (DE-627)490293514  |0 (DE-576)189471352  |4 aut 
700 1 |a Siegert, Elise  |d 1981-  |e VerfasserIn  |0 (DE-588)1163250538  |0 (DE-627)1027466273  |0 (DE-576)507855981  |4 aut 
700 1 |a Günther, Claudia  |d 1976-  |e VerfasserIn  |0 (DE-588)143813242  |0 (DE-627)704609908  |0 (DE-576)335655866  |4 aut 
700 1 |a Kötter, Ina  |e VerfasserIn  |4 aut 
700 1 |a Pfeiffer, Christiane  |e VerfasserIn  |4 aut 
700 1 |a Schmalzing, Marc  |e VerfasserIn  |4 aut 
700 1 |a Zeidler, Gabriele  |e VerfasserIn  |4 aut 
700 1 |a Korsten, Peter  |e VerfasserIn  |4 aut 
700 1 |a Susok, Laura  |e VerfasserIn  |4 aut 
700 1 |a Juche, Aaron  |e VerfasserIn  |4 aut 
700 1 |a Worm, Margitta  |e VerfasserIn  |4 aut 
700 1 |8 1\p  |a Jandová, Ilona  |e VerfasserIn  |0 (DE-588)1221646702  |0 (DE-627)1738963071  |4 aut 
700 1 |a Ehrchen, Jan  |e VerfasserIn  |4 aut 
700 1 |a Sunderkötter, Cord  |e VerfasserIn  |0 (DE-588)1119936004  |0 (DE-627)873055284  |0 (DE-576)480081107  |4 aut 
700 1 |a Keyßer, Gernot  |e VerfasserIn  |4 aut 
700 1 |a Ramming, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Schmeiser, Tim  |e VerfasserIn  |4 aut 
700 1 |a Kreuter, Alexander  |e VerfasserIn  |4 aut 
700 1 |a Lorenz, Hanns-Martin  |d 1962-  |e VerfasserIn  |0 (DE-588)112253865  |0 (DE-627)627277845  |0 (DE-576)167601369  |4 aut 
700 1 |a Hunzelmann, Nicolas  |e VerfasserIn  |4 aut 
700 1 |8 2\p  |a Kreuter, Michael  |d 1972-  |e VerfasserIn  |0 (DE-588)122645995  |0 (DE-627)082066795  |0 (DE-576)293362742  |4 aut 
773 0 8 |i Enthalten in  |t Chest  |d Amsterdam : Elsevier, 1935  |g 165(2024), 1 vom: Jan., Seite 132-145  |h Online-Ressource  |w (DE-627)320460819  |w (DE-600)2007244-2  |w (DE-576)09089202X  |x 1931-3543  |7 nnas  |a Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival a large cohort study of the German network for systemic sclerosis 
773 1 8 |g volume:165  |g year:2024  |g number:1  |g month:01  |g pages:132-145  |g extent:14  |a Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival a large cohort study of the German network for systemic sclerosis 
856 4 0 |u https://doi.org/10.1016/j.chest.2023.08.013  |x Resolving-System  |z kostenfrei 
883 |8 1\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 2\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20240628 
993 |a Article 
994 |a 2024 
998 |g 122645995  |a Kreuter, Michael  |m 122645995:Kreuter, Michael  |d 50000  |e 50000PK122645995  |k 0/50000/  |p 28  |y j 
998 |g 112253865  |a Lorenz, Hanns-Martin  |m 112253865:Lorenz, Hanns-Martin  |d 700000  |d 710000  |e 700000PL112253865  |e 710000PL112253865  |k 0/700000/  |k 1/700000/710000/  |p 26 
998 |g 115586032  |a Blank, Norbert  |m 115586032:Blank, Norbert  |d 910000  |d 910100  |d 50000  |e 910000PB115586032  |e 910100PB115586032  |e 50000PB115586032  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 5 
999 |a KXP-PPN1885170521  |e 4543073282 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1885170521","physDesc":[{"extent":"14 S.","noteIll":"Diagramme"}],"language":["eng"],"name":{"displayForm":["Pia Moinzadeh, MD, Francesco Bonella, MD, Max Oberste, BScPsych, Jithmi Weliwitage, MSc, Nobert Blank, MD, Gabriela Riemekasten, MD, Ulf Müller-Ladner, MD, Jörg Henes, MD, Elise Siegert, MD, Claudia Günther, MD, Ina Kötter, MD, Christiane Pfeiffer, MD, Marc Schmalzing, MD, Gabriele Zeidler, MD, Peter Korsten, MD, Laura Susok, MD, Aaron Juche, MD, Margitta Worm, MD, Ilona Jandova, MD, Jan Ehrchen, MD, Cord Sunderkötter, MD, Gernot Keyßer, MD, Andreas Ramming, MD, Tim Schmeiser, MD, Alexander Kreuter, MD, Hanns-Martin Lorenz, MD, Nicolas Hunzelmann, MD, and Michael Kreuter, MD"]},"id":{"eki":["1885170521"],"doi":["10.1016/j.chest.2023.08.013"]},"origin":[{"dateIssuedDisp":"January 2024","dateIssuedKey":"2024"}],"person":[{"given":"Pia","role":"aut","display":"Moinzadeh, Pia","family":"Moinzadeh"},{"given":"Francesco","role":"aut","display":"Bonella, Francesco","family":"Bonella"},{"given":"Max","family":"Oberste-Frielinghaus","role":"aut","display":"Oberste-Frielinghaus, Max"},{"display":"Weliwitage, Jithmi","role":"aut","family":"Weliwitage","given":"Jithmi"},{"display":"Blank, Norbert","role":"aut","family":"Blank","given":"Norbert"},{"family":"Riemekasten","role":"aut","display":"Riemekasten, Gabriela","given":"Gabriela"},{"display":"Müller-Ladner, Ulf","role":"aut","family":"Müller-Ladner","given":"Ulf"},{"family":"Henes","role":"aut","display":"Henes, Jörg Christoph","given":"Jörg Christoph"},{"family":"Siegert","role":"aut","display":"Siegert, Elise","given":"Elise"},{"given":"Claudia","display":"Günther, Claudia","role":"aut","family":"Günther"},{"display":"Kötter, Ina","role":"aut","family":"Kötter","given":"Ina"},{"given":"Christiane","family":"Pfeiffer","role":"aut","display":"Pfeiffer, Christiane"},{"given":"Marc","family":"Schmalzing","role":"aut","display":"Schmalzing, Marc"},{"family":"Zeidler","display":"Zeidler, Gabriele","role":"aut","given":"Gabriele"},{"given":"Peter","family":"Korsten","display":"Korsten, Peter","role":"aut"},{"given":"Laura","family":"Susok","role":"aut","display":"Susok, Laura"},{"given":"Aaron","display":"Juche, Aaron","role":"aut","family":"Juche"},{"family":"Worm","role":"aut","display":"Worm, Margitta","given":"Margitta"},{"given":"Ilona","family":"Jandová","role":"aut","display":"Jandová, Ilona"},{"family":"Ehrchen","display":"Ehrchen, Jan","role":"aut","given":"Jan"},{"display":"Sunderkötter, Cord","role":"aut","family":"Sunderkötter","given":"Cord"},{"given":"Gernot","family":"Keyßer","role":"aut","display":"Keyßer, Gernot"},{"given":"Andreas","family":"Ramming","display":"Ramming, Andreas","role":"aut"},{"family":"Schmeiser","role":"aut","display":"Schmeiser, Tim","given":"Tim"},{"role":"aut","display":"Kreuter, Alexander","family":"Kreuter","given":"Alexander"},{"display":"Lorenz, Hanns-Martin","role":"aut","family":"Lorenz","given":"Hanns-Martin"},{"given":"Nicolas","role":"aut","display":"Hunzelmann, Nicolas","family":"Hunzelmann"},{"role":"aut","display":"Kreuter, Michael","family":"Kreuter","given":"Michael"}],"title":[{"title_sort":"Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival","title":"Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival","subtitle":"a large cohort study of the German network for systemic sclerosis"}],"relHost":[{"note":["Gesehen am 09.11.2017"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1935 -"],"titleAlt":[{"title":"Diseases of the chest"},{"title":"for pulmonologists, cardiologists, cardiothoracic surgeons, critical care physicians, and related specialists"},{"title":"the cardiopulmonary and critical care journal"},{"title":"for pulmonologists, cardiologists, cardiothoracic surgeons, critical care physicians, and related specialists"}],"title":[{"title_sort":"Chest","title":"Chest","subtitle":"official publication of the American College of Chest Physicians ; for specialists in pulmonology, critical care, sleep medicine, thoracic surgery, cardiorespiratory interactions and related disciplines"}],"origin":[{"dateIssuedDisp":"1935-","publisherPlace":"Amsterdam ; Northbrook, Ill. [u.a.]","publisher":"Elsevier ; American College of Chest Physicians","dateIssuedKey":"1935"}],"corporate":[{"display":"American College of Chest Physicians","role":"isb"}],"id":{"zdb":["2007244-2"],"eki":["320460819"],"issn":["1931-3543"]},"recId":"320460819","disp":"Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival a large cohort study of the German network for systemic sclerosisChest","part":{"text":"165(2024), 1 vom: Jan., Seite 132-145","extent":"14","year":"2024","volume":"165","pages":"132-145","issue":"1"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}]}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Online verfügbar: 13. August 2023, Artikelversion: 8. Januar 2024"]} 
SRT |a MOINZADEHPIMPACTOFSY2024